1. DonaldsonRMJr. Normal bacterial populations of the intestine and their relation to intestinal function. N Engl J Med1964;270:994. CrossRef

2. DonaldsonRMJr. Normal bacterial populations of the intestine and their relation to intestinal function. N Engl J Med1964;270:1050. CrossRef

3. McEvoyA, DuttonJ, JamesOF. Bacterial contamination of the small intestine is an important cause of occult malabsorption in the elderly. Br Med J1983;287:789. CrossRef

4. McMahonM, LynchM, MullinsE, et al.Small intestinal bacterial overgrowth – an incidental finding?J Am Geriatr Soc1994;42:146. CrossRef

5. De BoissieuD, ChaussainM, BadoualJ, et al.Small‐bowel bacterial overgrowth in children with chronic diarrhea, abdominal pain or both. J Pediatr1996;128:203. CrossRef

6. RiordanSM, McIverCJ, WakefieldD, et al.Small intestinal bacterial overgrowth in the symptomatic elderly. Am J Gastroenterol1997;92:47.

7. ParlesakA, KleinB, SchecherK, et al.Prevalence of small bowel bacterial overgrowth and its association with nutrition intake in nonhospitalized older adults. J Am Geriatr Soc2003;51:788.

8. Torres LamR, Leon BaruaR, Berendson SeminarioR, et al.Small intestine bacterial overgrowth in patients with chronic diarrhea and normal control subjects. Rev Gastroenterol Peru2003;23:111.

9. TeoM, ChungS, ChittiL, et al.Small bowel bacterial overgrowth is a common cause of chronic diarrhea. J Gastroenterol Hepatol2004;19:904. CrossRef

10. MitsuiT, ShimaokaK, GotoY, et al.Small bowel bacterial overgrowth is not seen in healthy adults but is in disabled older adults. Hepatogastroenterology2006;53:82.

11. ChoungRS, RuffKC, MalhotraA, et al.Clinical predictors of small intestinal bacterial overgrowth by duodenal aspirate culture. Aliment Pharmacol Ther2011;33:1059. CrossRef

12. VantrappenG, JanssensJ, HellemansJ, et al.The interdigestive motor complex of normal subjects and patients with bacterial overgrowth of the small intestine. J Clin Invest1977;59:1158. CrossRef

13. PhillipsSF, QuigleyEM, KumarD, et al.Motility of the ileocolonic junction. Gut1988;29:390. CrossRef

14. OjettiV, PitoccoD, ScarpelliniE, et al.Small bowel bacterial overgrowth and type 1 diabetes. Eur Rev Med Pharmacol Sci2009;13:419.

15. ResminiE, ParodiA, SavarinoV, et al.Evidence of prolonged oro‐cecal transit time and small intestinal bacterial overgrowth in acromegalic patients. J Clin Endocrinol Metab2007;92:2119. CrossRef

16. StridH, SimrenM, StotzerPO, et al.Patients with chronic renal failure have abnormal small intestinal motility and a high prevalence of small intestinal bacterial overgrowth. Digestion2003;67:129. CrossRef

17. GeorgeNS, SankineniA, ParkmanHP. Small intestinal bacterial overgrowth in gastroparesis. Dig Dis Sci2014;59:645. CrossRef

18. TarnopolskyMA, PearceE, MattelianoA, et al.Bacterial overgrowth syndrome in myotonic muscular dystrophy is potentially treatable. Muscle Nerve2010;42:853. CrossRef

19. ReddymasuSC, McCallumRW. Small intestinal bacterial overgrowth in gastroparesis: are there any predictors?J Clin Gastroenterol2010;44:e8. CrossRef

20. LayritanoEC, BilottiAL, GabrielliM, et al.Association between hypothyroidism and small intestinal bacterial overgrowth. J Clin Endocrinol Metab2007;92:4180. CrossRef

21. MarieI, DucrottéP, DenisP, et al.Small intestinal bacterial overgrowth in systemic sclerosis. Rheumatology2009;48:1314. CrossRef

22. ParodiA, SessaregoM, GrecoA, et al.Small intestinal bacterial overgrowth in patients suffering from scleroderma: clinical effectiveness of its eradication. Am J Gastroenterol2008;103:1257. CrossRef

23. KrishnamurthyS, KellyMM, RohrmannCA, et al.Jejunal diverticulosis: a heterogeneous disorder caused by a variety of abnormalities of smooth muscle or myenteric plexus. Gastroenterology1983;85:538.

24. LakhaniSV, ShahHN, AlexanderK, et al.Small intestinal bacterial overgrowth and thiamine deficiency after Roux‐en‐Y gastric bypass surgery in obese patients. Nutr Res2008;28:293. CrossRef

25. PaikCN, ChoiMG, LimCH, et al.The role of small intestinal bacterial overgrowth in post‐gastrectomy patients. Neurogastroenterol Motil2011;23:e191. CrossRef

26. NealeG, GompertzD, SchönsbyH, et al.The metabolic and nutritional consequences of bacterial overgrowth in the small intestine. Am J Clin Nutr1972;25:1409.

27. KlausJ, SpaniolU, AdlerG, et al.Small intestinal bacterial overgrowth mimicking acute flare as a pitfall in patients with Crohn's disease. BMC Gastroenterol2009;9:61. CrossRef

28. LombardoL, FotiM, RuggiaO, et al.Increased incidence of small intestinal bacterial overgrowth during proton pump inhibitor therapy. Clin Gastroenterol Hepatol2010;8:504. CrossRef

29. LoWK, ChanWW. Proton pump inhibitor use and the risk of small intestinal bacterial overgrowth: a meta‐analysis. Clin Gastroenterol Hepatol2013;11:483. CrossRef

30. RatuapliSK, EllingtonTG, O'NeillMT, et al.Proton pump inhibitor therapy use does not predispose to small intestinal bacterial overgrowth. Am J Gastroenterol2012;107:730. CrossRef

31. GhoshalUC, GoelA, GhoshalU, et al.Chronic diarrhea and malabsorption due to hypogammaglobulinemia: a report of twelve patients. Indian J Gastroenterol2011;30:170. CrossRef

32. GhoshalUC, GhoshalU, MisraA, et al.Partially responsive celiac disease resulting from small intestinal bacterial overgrowth and lactose intolerance. BMC Gastroenterol2004;4:10. CrossRef

33. TursiA, BrandimarteG, GiorgettiG. High prevalence of small intestinal bacterial overgrowth in celiac patients with persistence of gastrointestinal symptoms after gluten withdrawal. Am J Gastroenterol2003;98:839. CrossRef

34. Rubio‐TapiaA, BartonSH, RosenblattJE, et al.Prevalence of small intestine bacterial overgrowth diagnosed by quantitative culture of intestinal aspirate in celiac disease. J Clin Gastroenterol2009;43:157. CrossRef

35. DewarDH, DonnellySC, McLaughlinSD, et al.Celiac disease: management of persistent symptoms in patients on a gluten‐free diet. World J Gastroenterol2012;18:1348. CrossRef

36. ChangMS, MinayaMT, ChengJ, et al.Double‐blind randomized controlled trial of rifaximin for persistent symptoms in patients with celiac disease. Dig Dis Sci2011;56:2939. CrossRef

37. LisowskaA, PogorzelskiA, OraczG, et al.Oral antibiotic therapy improves fat absorption in cystic fibrosis patients with small intestine bacteraial overgrowth. J Cyst Fibros2011;10:418. CrossRef

38. LisowskaA, WojtowiczJ, WalkowiakJ. Small intestinal bacterial overgrowth is frequent in cystic fibrosis: combined hydrogen and methane measurements are required for its detection. Acta Biochim Pol2009;56:631.

39. QuigleyEMM, QueraR. Small intestinal bacterial overgrowth: roles of antibiotics, prebiotics and probiotics. Gastroenterology2006;130(2 Suppl):304. CrossRef

40. MalikBA, XieYY, WineE, et al.Diagnosis and pharmacological management of small intestinal bacterial overgrowth in children with intestinal failure. Can J Gastroenterol2011;25:41.

41. QuigleyEM, StantonC, MurphyEF. The gut microbiota and the liver. Pathophysiological and clinical implications. J Hepatol2013;58:1020. CrossRef

42. AlmeidaJ, GalhenageS, YuJ, et al.Gut flora and bacterial translocation in chronic liver disease. World J Gastroenterol2006;12:1493.

43. GunnarsdottirS, SadikR, ShevS, et al.Small intestinal motility disturbances and bacterial overgrowth in patients with liver cirrhosis and portal hypertension. Am J Gastroenterol2003;98:1362. CrossRef

44. PandeC, KumarA, SarinSK. Small‐intestinal bacterial overgrowth in cirrhosis is related to the severity of liver disease. Aliment Pharmacol Ther2009;29:1273. CrossRef

45. JunDW, KimKT, LeeOY, et al.Association between small intestinal bacterial overgrowth and peripheral bacterial DNA in cirrhotic patients. Dig Dis Sci2010;55:1465. CrossRef

46. BauerTM, SchwachaH, SteinbrücknerB, et al.Small intestinal bacterial overgrowth in human cirrhosis is associated with systemic endotoxemia. Am J Gastroenterol2002;97:2364. CrossRef

47. BauerT, SteinbrücknerB, BrinkmannF, et al.Small intestinal bacterial overgrowth in patients with cirrhosis: prevalence and relation with spontaneous bacterial peritonitis. Am J Gastroenterol2001;96:2962. CrossRef

48. GuptaA, DhimanRK, KumariS, et al.Role of small intestinal bacterial overgrowth and delayed gastrointestinal transit time in cirrhotic patients with minimal hepatic encephalopathy. J Hepatol2010;53:849. CrossRef

49. MieleL, ValenzaV, La TorreG, et al.Increased intestinal permeability and tight junction alterations in nonalcoholic fatty liver disease. Hepatology2009;49:1877. CrossRef

50. ParodiA, PaolinoS, GrecoA, et al.Small intestinal bacterial overgrowth in rosacea: clinical effectiveness of its eradication. Clin Gastroenterol Hepatol2008;6:759. CrossRef

51. WeinstockLB, KlutkeCG, LinHC. Small intestinal bacterial overgrowth in patients with interstitial cystitis and gastrointestinal symptoms. Dig Dis Sci2008;53:1246. CrossRef

52. WeinstockLB, FernSE, DuntleySP. Restless legs syndrome in patients with irritable bowel syndrome: response to small intestinal bacterial overgrowth therapy. Dig Dis Sci2008;53:1252. CrossRef

53. DobbsRJ, CharlettA, DobbsSM, et al.Leukocyte‐subset counts in idiopathic parkinsonism provide clues to a pathogenic pathway involving small intestinal bacterial overgrowth. A prevalence study. Gut Pathog2012;4:12. CrossRef

54. GabrielliM, BonazziP, ScarpelliniE, et al.Prevalence of small intestinal bacterial overgrowth in Parkinson's disease. Mov Disord2011;26:889. CrossRef

55. KimKM, KimBT, LeeDJ, et al.Erosive esophagitis may be related to small intestinal bacterial overgrowth. Scand J Gastroenterol2012;47:493. CrossRef

56. SabateJM, JouetP, HarnoisF, et al.High prevalence of small intestinal bacterial overgrowth in patients with morbid obesity: a contributor to severe steatosis. Obes Surg2008;18:371. CrossRef

57. PimentelM, ChowEJ, LinHC. Eradication of small intestinal bacterial overgrowth reduces symptoms of irritable bowel syndrome. Am J Gastroenterol2000;95:3503. CrossRef

58. PimentelM, ChowEJ, LinHC. Normalization of lactulose breath testing correlates with symptom improvement in irritable bowel syndrome: a double‐blind, randomized, placebo‐controlled study. Am J Gastroenterol2003;98:412.

59. ScarpelliniE, GiorgioV, GabrielliM, et al.Prevalence of small intestinal bacterial overgrowth in children with irritable bowel syndrome: a case‐control study. J Pediatr2009;155:416. CrossRef

60. PeraltaS, CottoneC, DoveriT, et al.Small intestine bacterial overgrowth and irritable bowel syndrome‐related symptoms: experience with Rifaximin. World J Gastroenterol2009;15:2628. CrossRef

61. EspositoI, de LeoneA, Di GregorioG, et al.Breath test for differential diagnosis between small intestinal bacterial overgrowth and irritable bowel disease: an observation on non‐absorbable antibiotics. World J Gastroenterol2007;13:6016. CrossRef

62. RanaSV, SharmaS, KaurJ, et al.Comparison of lactulose and glucose breath test for diagnosis of small intestinal bacterial overgrowth in patients with irritable bowel syndrome. Digestion2012;85:243. CrossRef

63. HaslerWL. Lactulose breath testing, bacterial overgrowth, and IBS: just a lot of hot air?Gastroenterology2003;125:1898. CrossRef

64. BrattenJR, SpanierJ, JonesMP. Lactulose breath testing does not discriminate patients with irritable bowel syndrome from healthy controls. Am J Gastroenterol2008;103:958. CrossRef

65. QuigleyEM. A 51‐year‐old with irritable bowel syndrome: test or treat for bacterial overgrowth?Clin Gastroenterol Hepatol2007;5:1140. CrossRef

66. VannerS. The lactulose breath test for diagnosing SIBO in IBS patients: another nail in the coffin. Am J Gastroenterol2008;103:964. CrossRef

67. VannerS. The small intestinal bacterial overgrowth. Irritable bowel syndrome hypothesis: implications for treatment. Gut2008;57:1315. CrossRef

68. ParodiA, DulbeccoP, SavarinoE, et al.Positive glucose breath testing is more prevalent in patients with IBS‐like symptoms compared with controls of similar age and gender distribution. J Clin Gastroenterol2009;43:962. CrossRef

69. FordAC, SpiegelBM, TalleyNJ, et al.Small intestinal bacterial overgrowth in irritable bowel syndrome: systematic review and meta‐analysis. Clin Gastroenterol Hepatol2009;7:1279. CrossRef

70. SpiegelBM, CheyWD, ChangL. Bacterial overgrowth and irritable bowel syndrome: unifying hypothesis or a spurious consequence of proton pump inhibitors?Am J Gastroenterol2008;103:2972. CrossRef

71. SpiegelBM. Questioning the bacterial overgrowth hypothesis of irritable bowel syndrome: an epidemiologic and evolutionary perspective. Clin Gastroenterol Hepatol2011;9:461. CrossRef

72. PimentelM, ParkS, MirochaJ, et al.The effect of a nonabsorbed oral antibiotic (rifaximin) on the symptoms of the irritable bowel syndrome: a randomized trial. Ann Intern Med2006;145:557. CrossRef

73. PimentelM, LemboA, CheyWD, et al.TARGET Study Group. Rifaximin therapy for patients with irritable bowel syndrome without constipation. N Engl J Med2011;364:22. CrossRef

74. SimonGL, GorbachSL. The human intestinal microflora. Dig Dis Sci1986;31:147. CrossRef

75. ToskesPP. Bacterial overgrowth of the gastrointestinal tract. Adv Intern Med1993;38:387.

76. ZhaoJ, FoxM, CongY, et al.Lactose intolerance in patients with chronic functional diarrhea; the role of small intestinal bacterial overgrowth. Aliment Pharmacol Ther2010;31:892.

77. GiulianoV, BassottiG, MourvakiE, et al.Small intestinal bacterial overgrowth and warfarin dose requirement variability. Thromb Res2010;126:12. CrossRef

78. FanX, SellinJH. Review article: small intestinal bacterial overgrowth, bile acid malabsorption and gluten intolerance as possible causes of chronic watery diarrhoea. Aliment Pharmacol Ther2009;29:1069. CrossRef

79. GuarnerF, MalageladaJR. Gut flora in health and disease. Lancet2003;361:512. CrossRef

80. HusebyeE. The pathogenesis of gastrointestinal bacterial overgrowth. Chemotherapy2005;51(Suppl 1):1. CrossRef

81. RiordanSM, McIverCJ, WalkerBM, et al.The lactulose breath hydrogen test and small intestinal bacterial overgrowth. Am J Gastroenterol1996;91:1795.

82. RiordanSM, McIverCJ, DuncombeVM, et al.Small intestinal bacterial overgrowth and the irritable bowel syndrome. Am J Gastroenterol2001;96:2506. CrossRef

83. BardhanPK, GyrK, BeglingerC, et al.Diagnosis of bacterial overgrowth after culturing proximal small‐bowel aspirate obtained during routine upper gastrointestinal endoscopy. Scand J Gastroenterol1992;27:253. CrossRef

84. PosserudI, StotzerPO, BjornssonES, et al.Small intestinal bacterial overgrowth in patients with irritable bowel syndrome. Gut2007;56:802. CrossRef

85. Leon‐BaruaR, GilmanRH, RodriguezC, et al.Comparison of three methods to obtain upper small bowel contents for culture. Am J Gastroenterol1993;88:925.

86. RiordanSM, McIverCJ, DuncombeVM, et al.Bacteriologic analysis of mucosal biopsy specimens for detecting small‐intestinal bacterial overgrowth. Scand J Gastroenterol1995;30:681. CrossRef

87. ReidMC, LachsMS, FeinsteinAR. Use of methodological standards in diagnostic test research. Getting better but still not good. JAMA1995;274:645. CrossRef

88. KhoshiniR, DaiSC, LezcanoS, et al.A systematic review of diagnostic tests for small intestinal bacterial overgrowth. Dig Dis Sci2008;53:1443. CrossRef

89. HamiltonI, WorsleyBW, CobdenI, et al.Simultaneous culture of saliva and jejunal aspirate in the investigation of small bowel bacterial overgrowth. Gut1982;23:847. CrossRef

90. FraherMH, O'ToolePW, QuigleyEMM. Techniques used to characterize the intestinal microbiota: a guide for the clinician. Nat Rev Gastroenterol Hepatol2012;9:312. CrossRef

91. SimrenM, StotzerPO. Use and abuse of hydrogen breath tests. Gut2006;55:297. CrossRef

92. FrommH, HofmannAF. Breath test for altered bile‐acid metabolism. Lancet1971;2:621. CrossRef

93. SherrHP, SasakiY, NewmanA, et al.Detection of bacterial deconjugation of bile salts by a convenient breath‐analysis technic. N Engl J Med1971;285:656. CrossRef

94. DonaldsonRMJr. Role of enteric microorganisms in malabsorption. Fed Proc1967;26:1426.

95. DonaldIP, KitchingmamG, DonaldF, et al.The diagnosis of small bowel bacterial overgrowth in elderly patients. J Am Geriatr Soc1992;40:692. CrossRef

96. LauterburgBH, NewcomerAD, HofmannAF. Clinical value of the bile acid breath test. Evaluation of the Mayo Clinic experience. Mayo Clin Proc1978;53:227.

97. KingCE, ToskesPP, GuilarteTR, et al.Comparison of the one‐gram d‐[14C]xylose breath test to the [14C]bile acid breath test in patients with small‐intestine bacterial overgrowth. Dig Dis Sci1980;25:53. CrossRef

98. FergusonJ, WalkerK, ThomsonAB. Limitations in the use of 14C‐glycocholate breath and stool bile acid determinations in patients with chronic diarrhea. J Clin Gastroenterol1986;8:258. CrossRef

99. ToskesPP, KingCE, SpiveyJC, et al.Xylose catabolism in the experimental rat blind loop syndrome: studies, including use of a newly developed d‐[14C]xylose breath test. Gastroenterology1978;74:691.

100. KingCE, ToskesPP, SpiveyJC, et al.Detection of small intestine bacterial overgrowth by means of a 14C‐D‐xylose breath test. Gastroenterology1979;77:75.

101. RumessenJJ, Gudmand‐HoyerE, BachmannE, et al.Diagnosis of bacterial overgrowth of the small intestine. Comparison of the 14C‐D‐xylose breath test and jejunal cultures in 60 patients. Scand J Gastroenterol1985;20:1267. CrossRef

102. KingCE, ToskesPP. Comparison of the 1‐gram [14C]xylose, 10‐gram lactulose‐H2, and 80‐gram glucose‐H2 breath tests in patients with small intestine bacterial overgrowth. Gastroenterology1986;91:1447.

103. RiordanSM, McIverCJ, DuncombeVM, et al.Factors influencing the 1g 14C‐D‐xylose breath test for bacterial overgrowth. Am J Gastroenterol1995;90:1455.

104. ValdovinosMA, CamilleriM, ThomfordeGM, et al.Reduced accuracy of 14C‐D‐xylose breath test for detecting bacterial overgrowth in gastrointestinal motility disorders. Scand J Gastroenterol1993;28:963. CrossRef

105. LewisSJ, YoungG, MannM, et al.Improvement in specificity of [14C]d‐xylose breath test for bacterial overgrowth. Dig Dis Sci1997;42:1587. CrossRef

106. RomagnuoloJ, SchillerD, BaileyRJ. Using breath tests wisely in a gastroenterology practice: an evidence‐based review of indications and pitfalls in interpretation. Am J Gastroenterol2002;97:1113. CrossRef

107. KerlinP, WongL. Breath hydrogen testing in bacterial overgrowth of the small intestine. Gastroenterology1988;95:982.

108. StrocchiA, FurneJ, EllisC, et al.Methanogens outcompete sulphate reducing bacteria for H2 in the human colon. Gut1994;35:1098. CrossRef

109. CorazzaGR, StrocchiA, GasbarriniG. Fasting breath hydrogen in celiac disease. Gastroenterology1987;93:53.

110. PimentelM, KongY, ParkS. Breath testing to evaluate lactose intolerance in irritable bowel syndrome correlates with lactulose testing and may not reflect true lactose malabsorption. Am J Gastroenterol2003;98:2700. CrossRef

111. NuceraG, GabrielliM, LupascuA, et al.Abnormal breath tests to lactose, fructose and sorbitol in irritable bowel syndrome may be explained by small intestinal bacterial overgrowth. Aliment Pharmacol Ther2005;21:1391. CrossRef

112. ThompsonDG, BinfieldP, De BelderA, et al.Extra intestinal influences on exhaled breath hydrogen measurements during the investigation of gastrointestinal disease. Gut1985;26:1349. CrossRef

113. GasbarriniA, CorazzaGR, GasbarriniG, et al.Methodology and indications of H2 breath testing in gastrointestinal diseases: the Rome Consensus Conference. Aliment Pharmacol Ther2009;29(Suppl 1):1.

114. RiordanSM, McIverCJ, BolinTD, et al.Fasting breath hydrogen concentrations in gastric and small‐intestinal bacterial overgrowth. Scand J Gastroenterol1995;30:252. CrossRef

115. CorazzaGR, MenozziMG, StrocchiA, et al.The diagnosis of small bowel bacterial overgrowth. Reliability of jejunal culture and inadequacy of breath hydrogen testing. Gastroenterology1990;98:302.

116. BondJH, LevittMD. Use of pulmonary hydrogen (H2) measurements to quantitate carbohydrate absorption. Study of partially gastrectomized patients. J Clin Invest1972;51:1219. CrossRef

117. PeledY, WeinbergD, HallakA, et al.Factors affecting methane production in humans. Gastrointestinal diseases and alterations of colonic flora. Dig Dis Sci1987;32:267. CrossRef

118. McKayLF, EastwoodMA, BrydonWG. Methane excretion in man–a study of breath, flatus, and faeces. Gut1985;26:69. CrossRef

119. LeibyA, MehtaD, GopalareddyV, et al.Bacterial overgrowth and methane production in children with encopresis. J Pediatr2010;156:766. CrossRef

120. MinochaA, RashidS. Reliability and reproducibility of breath hydrogen and methane in male diabetic subjects. Dig Dis Sci1997;42:672. CrossRef

121. EckburgPB, BikEM, BernsteinCN, et al.Diversity of the human intestinal microbial flora. Science2005;308:1635. CrossRef

122. SamuelBS, GordonJI. A humanized gnotobiotic mouse model of host‐archaeal‐bacterial mutualism. Proc Natl Acad Sci U S A2006;103:10011. CrossRef

123. RhodesJM, MiddletonP, JewellDP. The lactulose hydrogen breath test as a diagnostic test for small‐bowel bacterial overgrowth. Scand J Gastroenterol1979;14:333. CrossRef

124. ShararaAI, AounE, Abdul‐BakiH, et al.A randomized double‐blind placebo‐controlled trial of rifaximin in patients with abdominal bloating and flatulence. Am J Gastroenterol2006;101:326. CrossRef

125. WaltersB, VannerSJ. Detection of bacterial overgrowth in IBS using the lactulose H2 breath test: comparison with 14C‐D‐xylose and healthy controls. Am J Gastroenterol2005;100:1566. CrossRef

126. YuD, CheesmanF, VannerS. Combined oro‐cecal scintigraphy and lactulose hydrogen breath testing demonstrate that breath testing detects oro‐cecal transit, not small intestinal bacterial overgrowth in patients with IBS. Gut2011;60:334. CrossRef

127. MetzG, GassullMA, DrasarBS, et al.Breath‐hydrogen test for small‐intestinal bacterial colonisation. Lancet1976;1:668. CrossRef

128. GhoshalUC, GhoshalU, DasK, et al.Utility of hydrogen breath tests in diagnosis of small intestinal bacterial overgrowth in malabsorption syndrome and its relationship with oro‐cecal transit time. Indian J Gastroenterol2006;25:6.

129. MendozaE, CrismattC, MatosR, et al.[Diagnosis of small intestinal bacterial overgrowth in children: the use of lactulose in the breath hydrogen test as a screening test]. Biomedica2007;27:325. CrossRef

130. SaltzmanJR, KowdleyKV, PedrosaMC, et al.Bacterial overgrowth without clinical malabsorption in elderly hypochlorhydric subjects. Gastroenterology1994;107:1214.

131. BjorneklettA, FausaO, MidtvedtT. Small‐bowel bacterial overgrowth in the postgastrectomy syndrome. Scand J Gastroenterol1983;18:277. CrossRef

132. BardhanPK, FegerA, KogonM, et al.Urinary choloyl‐PABA excretion in diagnosing small intestinal bacterial overgrowth: evaluation of a new noninvasive method. Dig Dis Sci2000;45:474. CrossRef

133. PatneyNL, MehrotraMP, KhannaHK, et al.Urinary indican as a screening index of jejunal bacterial flora in Indian adulthood cirrhosis. Indian J Med Sci1979;33:150.

134. PatneyNL, SaxenaSK, MehrotraMP, et al.A correlative study of indicanuria and jejunal bacteriology in diabetes mellitus. Indian J Med Sci1979;33:115.

135. KerckhoffsAP, VisserMR, SamsomM, et al.Critical evaluation of diagnosing bacterial overgrowth in the proximal small intestine. J Clin Gastroenterol2008;42:1095. CrossRef

136. LauritanoEC, GabrielliM, ScarpelliniE, et al.Antibiotic therapy in small intestinal bacterial overgrowth: rifaximin versus metronidazole. Eur Rev Med Pharmacol Sci2009;13:111.

137. MajewskiM, ReddymasuSC, SostarichS, et al.Efficacy of rifaximin, a nonabsorbed oral antibiotic, in the treatment of small intestinal bacterial overgrowth. Am J Med Sci2007;333:266. CrossRef

138. YangJ, LeeHR, LowK, et al.Rifaximin versus other antibiotics in the primary treatment and retreatment of bacterial overgrowth in IBS. Dig Dis Sci2008;53:169. CrossRef

139. FurnariM, ParodiA, GemignaniL, et al.Clinical trial: the combination of rifaximin with partially hydrolysed guar gum is more effective than rifaximin alone in eradicating small intestinal bacterial overgrowth. Aliment Pharmacol Ther2010;32:1000. CrossRef

140. LauritanoEC, GabrielliM, ScarpelliniE, et al.Small intestinal bacterial overgrowth recurrence after antibiotic therapy. Am J Gastroenterol2008;103:2031. CrossRef

141. UribarriJ, OhMS, CarrollHJ. D‐lactic acidosis. Medicine1998;77:73. CrossRef

142. SpinucciG, GuidettiM, LanzoniE, et al.Endogenous ethanol production in a patient with chronic intestinal pseudo‐obstruction and small bowel bacterial overgrowth. Eur J Gastroenterol Hepatol2006;18:799. CrossRef

143. ColeCR, FremJC, SchmotzerB, et al.The rate of bloodstream infection is high in infants with short bowel syndrome: relationship with small bowel bacterial overgrowth, enteral feeding and inflammatory and immune responses. J Pediatr2010;156:941. CrossRef

144. SungYK, GwakGY, ChoiMS, et al.A case of non‐alcoholic steatohepatitis and small intestinal bacterial overgrowth with peripheral edema caused by intestinal bypass surgery and relived by repair. Gut Liver2012;6:520. CrossRef

145. McGillDB, HumphreysSR, BaggrnstossAH, et al.Cirrhosis and death after jejuno‐ileal bypass. Gastroenterology1972;63:872.

146. SteinHB, SchlappnerOL, BoykoW, et al.The intestinal bypass: arthritis‐dermatitis syndrome. Arthritis Rheum1981;24:684. CrossRef

147. LichtmanSM, WangJ, SartorRB, et al.Reactivation of arthritis induced by small bowel bacterial overgrowth in rates: role of cytokines, bacteria and bacterial polymers. Infect Immun1995;63:2295.

148. WalzerN, BuchmanAL. Development of Crohn's disease in patients with intestinal failure: a role for bacteria?J Clin Gastroenterol2010;44:361.

149. FunayamaY, SasakiI, NaitoH, et al.Monitoring and antibacterial treatment for postoperative bacterial overgrowth in Crohn's disease. Dis Colon Rectum1999;42:1072. CrossRef

150. CastiglioneF, RispoA, Di GirolamoE, et al.Antibiotic treatment of small bowel bacterial overgrowth in patients with Crohn's disease. Aliment Pharmacol Ther2003;18:1107. CrossRef

151. LapingaPJ, AbrahamSC, MurrayJA, et al.Small intestinal bacterial overgrowth: histopathologic features and clinical correlates in an underrecognized entity. Arch Pathol Lab Med2010;134:264.

152. FundaroC, FantacciC, AnsuiniV, et al.Fecal calprotectin concentration in children affected by SIBO. Eur Rev Med Pharmacol Sci2011;15:1328.

153. MontaltoM, SantoroL, DalvaiS, et al.Fecal calprotectin concentrations in patients with small intestinal bacterial overgrowth. Dig Dis2008;26:183. CrossRef

154. BhatP, ShantakumariS, RajanD, et al.Bacterial flora of the gastrointestinal tract in southern Indian control subjects and patients with tropical sprue. Gastroenterology1972;62:11.

155. GhoshalUC, KumarS, MehrotraM, et al.Frequency of small intestinal bacterial overgrowth in patients with irritable bowel syndrome and chronic non‐specific diarrhea. J Neurogastroenterol Motil2010;16:40. CrossRef

156. RamakrishnaBS, VenkataramanS, MukhopadhyaA. Tropical malabsorption. Postgrad Med J2006;82:779. CrossRef

157. RamakrishnaBS. Tropical sprue: a riddle wrapped in a mystery inside an enigma. Indian J Med Res2013;137:12.

158. KorpePS, PetriWA. Environmental enteropathy: critical implications of a poorly understood condition. Trends Mol Med2012;18:328. CrossRef

159. TrehanI, ShulmanRJ, OuCN, et al.A randomized, double‐blind, placebo‐controlled trial of rifaximin, a nonabsorbable antibiotic, in the treatment of tropical enteropathy. Am J Gastroenterol2009;104:2326. CrossRef